[1]
Bakyt, L. and Bulanin, D. 2025. Evaluation of CCR5 inhibition in breast cancer using novel, potent inhibitors. Eurasian Journal of Applied Biotechnology. 3s (Nov. 2025). DOI:https://doi.org/10.11134/btp.3s.2025.32.